Insider Stock Trading History of Galen Partners Iii L P


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Galen Partners Iii L P since year 2005. The trader's CIK number is 1034486. At the time of this reporting, Galen Partners Iii L P is the 10% Owner of Acura Pharmaceuticals, Inc . (stock ticker symbol ACUR.OB). See this page for all insider trading activities at Acura Pharmaceuticals, Inc .


Stock purchases, sales, and option exercises reported by insider Galen Partners Iii L P since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-06-16 ACUR Acura Pharmaceuticals, Inc Sale 100,923 1.08 109,400
2015-06-17 ACUR Acura Pharmaceuticals, Inc Sale 3,900 1.05 4,095
2015-01-08 ACUR Acura Pharmaceuticals, Inc Sale 100,000 .60 60,200
2015-01-09 ACUR Acura Pharmaceuticals, Inc Sale 36,000 .65 23,436
2015-01-12 ACUR Acura Pharmaceuticals, Inc Sale 35,000 .64 22,470
2014-03-03 ACUR Acura Pharmaceuticals, Inc Sale 2,500 2.00 5,000
2014-02-28 ACUR Acura Pharmaceuticals, Inc Sale 147,480 2.00 295,697
2014-02-27 ACUR Acura Pharmaceuticals, Inc Sale 192,479 2.04 393,042
2014-02-26 ACUR Acura Pharmaceuticals, Inc Sale 11,301 1.95 22,070
2014-02-24 ACUR Acura Pharmaceuticals, Inc Sale 43,747 1.97 86,006
2014-02-21 ACUR Acura Pharmaceuticals, Inc Sale 272 1.95 530
2014-02-18 ACUR Acura Pharmaceuticals, Inc Sale 2,200 1.95 4,290
2013-10-10 ACUR Acura Pharmaceuticals, Inc Sale 4,200 2.05 8,610
2013-07-02 ACUR Acura Pharmaceuticals, Inc Sale 200,000 2.15 430,000
2013-06-17 ACUR Acura Pharmaceuticals, Inc Sale 20,446 2.15 43,958
2013-06-12 ACUR Acura Pharmaceuticals, Inc Sale 3,469 2.20 7,631
2013-06-14 ACUR Acura Pharmaceuticals, Inc Sale 27,814 2.15 59,800
2013-06-07 ACUR Acura Pharmaceuticals, Inc Sale 11,796 2.19 25,833
2013-06-10 ACUR Acura Pharmaceuticals, Inc Sale 9,700 2.21 21,437
2013-06-04 ACUR Acura Pharmaceuticals, Inc Sale 22,802 2.21 50,392
2013-06-05 ACUR Acura Pharmaceuticals, Inc Sale 6,650 2.21 14,696
2013-06-06 ACUR Acura Pharmaceuticals, Inc Sale 10,001 2.13 21,302
2013-05-30 ACUR Acura Pharmaceuticals, Inc Sale 12,860 2.26 29,012
2013-05-31 ACUR Acura Pharmaceuticals, Inc Sale 18,699 2.25 42,072
2013-05-21 ACUR Acura Pharmaceuticals, Inc Sale 47,410 2.30 108,995
2013-05-16 ACUR Acura Pharmaceuticals, Inc Sale 42,599 2.21 94,101
2013-05-17 ACUR Acura Pharmaceuticals, Inc Sale 54,460 2.36 128,307
2013-05-20 ACUR Acura Pharmaceuticals, Inc Sale 68,993 2.40 165,238
2013-05-15 ACUR Acura Pharmaceuticals, Inc Sale 23,585 2.27 53,608
2013-05-14 ACUR Acura Pharmaceuticals, Inc Sale 87,399 2.44 213,253
2013-05-13 ACUR Acura Pharmaceuticals, Inc Sale 72,450 2.21 160,042
2013-05-03 ACUR Acura Pharmaceuticals, Inc Sale 27,117 2.26 61,257
2013-05-06 ACUR Acura Pharmaceuticals, Inc Sale 105,300 2.12 223,551
2013-05-07 ACUR Acura Pharmaceuticals, Inc Sale 20,887 2.23 46,640
2013-05-02 ACUR Acura Pharmaceuticals, Inc Sale 49,937 2.47 123,344
2013-04-30 ACUR Acura Pharmaceuticals, Inc Sale 18,794 2.48 46,571
2013-05-01 ACUR Acura Pharmaceuticals, Inc Sale 106,027 2.37 251,708
2013-04-29 ACUR Acura Pharmaceuticals, Inc Sale 13,642 2.56 34,896
2013-04-25 ACUR Acura Pharmaceuticals, Inc Sale 16,700 2.67 44,555
2013-04-26 ACUR Acura Pharmaceuticals, Inc Sale 26,000 2.56 66,430
2013-04-17 ACUR Acura Pharmaceuticals, Inc Sale 238,756 3.20 764,974
2013-04-12 ACUR Acura Pharmaceuticals, Inc Sale 13,200 2.22 29,317
2013-04-16 ACUR Acura Pharmaceuticals, Inc Sale 21,800 2.11 45,932
2013-04-15 ACUR Acura Pharmaceuticals, Inc Sale 4,303 2.10 9,023
2013-04-10 ACUR Acura Pharmaceuticals, Inc Sale 25,118 2.16 54,380
2013-04-11 ACUR Acura Pharmaceuticals, Inc Sale 96,336 2.24 215,985
2013-04-05 ACUR Acura Pharmaceuticals, Inc Sale 99,933 2.16 215,555
2013-04-08 ACUR Acura Pharmaceuticals, Inc Sale 80,554 2.16 173,835
2013-04-09 ACUR Acura Pharmaceuticals, Inc Sale 20,000 2.14 42,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Galen Partners Iii L P (10% Owner of Acura Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.